KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Gross Profit (2016 - 2025)

Astrana Health (ASTH) has disclosed Gross Profit for 16 consecutive years, with $95.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 88.28% to $95.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $341.5 million through Dec 2025, up 25.85% year-over-year, with the annual reading at $341.5 million for FY2025, 25.85% up from the prior year.
  • Gross Profit hit $95.0 million in Q4 2025 for Astrana Health, down from $97.2 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $97.2 million in Q3 2025 to a low of $23.3 million in Q4 2021.
  • Historically, Gross Profit has averaged $60.3 million across 5 years, with a median of $63.3 million in 2023.
  • Biggest five-year swings in Gross Profit: plummeted 41.38% in 2021 and later skyrocketed 88.28% in 2025.
  • Year by year, Gross Profit stood at $23.3 million in 2021, then skyrocketed by 76.64% to $41.1 million in 2022, then decreased by 5.13% to $39.0 million in 2023, then increased by 29.5% to $50.5 million in 2024, then surged by 88.28% to $95.0 million in 2025.
  • Business Quant data shows Gross Profit for ASTH at $95.0 million in Q4 2025, $97.2 million in Q3 2025, and $78.0 million in Q2 2025.